Show Health and Fitness Publications

Mon, September 26, 2011

[ Mon, Sep 26th 2011 ] - Market Wire

InSite Vision Selects Quintiles as Contract Resea .. le Phase 3 Clinical Trial of AzaSite Plusa" and D

[ Mon, Sep 26th 2011 ] - Market Wire

Health Net Sponsors 2011 Congressional Medal of Honor Convention and Star-Studded Tribute Concert

[ Mon, Sep 26th 2011 ] - Market Wire

Zynex Receives FDA 510(k) Clearance for the NexWave Medical Device

[ Mon, Sep 26th 2011 ] - Market Wire

Alnylam Initiates Phase I Clinical Study of ALN-P .. ting PCSK9 for the Treatment of Severe Hyperchole

[ Mon, Sep 26th 2011 ] - Market Wire

Synta Announces Presentation of Results of Ganete .. udy in Combination with Docetaxel in Solid Tumors

[ Mon, Sep 26th 2011 ] - Market Wire

iCo Therapeutics and JDRF Partner to Investigate iCo-007 in Diabetic Macular Edema

[ Mon, Sep 26th 2011 ] - Market Wire

ARIAD Announces Long-Term Follow Up of Patients w .. stant CML Treated with Ponatinib in Phase 1 Trial

[ Mon, Sep 26th 2011 ] - Market Wire

Millennium y Seattle Genetics presentan datos cln .. uximab Vedotin) en pacientes peditricos en reunin

[ Mon, Sep 26th 2011 ] - Market Wire

National Hospice and Palliative Care Expert Joins Amedisys

Sat, September 24, 2011

[ Sat, Sep 24th 2011 ] - Market Wire

FDA lsst Soliris® (Eculizumab) zur Behandlung al .. atypischem hmolytisch-urmischem Syndrom (aHUS) zu

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium en Seattle Genetics presenteren klinis .. brentuximab vedotin) bij pediatrische patinten op

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium et Seattle Genetics pr©sentent, la?oc .. de la?EMCC, des donn©es cliniques concernant la?

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium und Seattle Genetics legen auf der EMC .. n zu ADCETRISa" (Brentuximab Vedotin) bei pdiatri

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium et Seattle Genetics pr©sentent la?occ .. e la?EMCC des donn©es cliniques concernant la?ut

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium et Seattle Genetics pr©sentent, .. occasion de la r©union annuelle de la?EMCC,&#

[ Sat, Sep 24th 2011 ] - Market Wire

Millennium and Seattle Genetics Present Clinical .. mab Vedotin) in Pediatric Patients at EMCC Annual

Fri, September 23, 2011

[ Fri, Sep 23rd 2011 ] - Market Wire

Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Allos Therapeutics, Inc.

[ Fri, Sep 23rd 2011 ] - Market Wire

Soliris (eculizumab) goedgekeurd door FDA voor al .. met atypisch hemolytisch uremisch syndroom (aHUS)

[ Fri, Sep 23rd 2011 ] - Market Wire

Celgene: reglementaire update inzake REVLIMID

[ Fri, Sep 23rd 2011 ] - Market Wire

Glancy Binkow & Goldberg LLP Announces Investigation of American Medical Alert Corp.

[ Fri, Sep 23rd 2011 ] - Market Wire

European CHMP Adopts Positive Opinion for Evipler .. Tablet Regimen for the Treatment of HIV Infection

[ Fri, Sep 23rd 2011 ] - Market Wire

MISE JOUR RGLEMENTAIRE DE CELGENE AU SUJET DE REVLIMID®

[ Fri, Sep 23rd 2011 ] - Market Wire

Celgene prsentiert aktuelle Informationen zur Marktzulassung von REVLIMID®

[ Fri, Sep 23rd 2011 ] - Market Wire

AGGIORNAMENTO REGOLATORIO DI CELGENE CIRCA REVLIMID®

[ Fri, Sep 23rd 2011 ] - Market Wire

Celgene Regulatory Update on REVLIMID®

Thu, September 22, 2011

[ Thu, Sep 22nd 2011 ] - Market Wire

Enzon Announces Reduction in Force to Align Operations with Research and Development Activities

[ Thu, Sep 22nd 2011 ] - Market Wire

U.S. Physical Therapy to Present at The Sixth Annual JMP Securities Healthcare Conference

[ Thu, Sep 22nd 2011 ] - Market Wire

U.S. Physical Therapy to Present at the The Sixth Annual JMP Securities Healthcare Conference

[ Thu, Sep 22nd 2011 ] - Market Wire

Brain Resource Opens U.S. Headquarters in San Francisco

[ Thu, Sep 22nd 2011 ] - Market Wire

PFCD Hill Briefing Demonstrates How Health Indices Promote Prevention and Improve Overall Health

[ Thu, Sep 22nd 2011 ] - Market Wire

Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Dendreon Corporation

[ Thu, Sep 22nd 2011 ] - Market Wire

dermaPACE Pivotal Phase III Clinical Trial Data i .. r Healing to Be Presented at Plastic Surgery 2011

[ Thu, Sep 22nd 2011 ] - Market Wire

Columbia Laboratories Extends Stockholder Rights .. rve Use of Net Operating Losses under Section 382

[ Thu, Sep 22nd 2011 ] - Market Wire

The Future of Ablation Therapies Conference

Wed, September 21, 2011

[ Wed, Sep 21st 2011 ] - Market Wire

Less Than Two Weeks Remain before Deadline in Cla .. tion Lawsuit against Dendreon, Says Hagens Berman

[ Wed, Sep 21st 2011 ] - Market Wire

Osiris Therapeutics to Present at the Sixth Annual JMP Securities Healthcare Conference

[ Wed, Sep 21st 2011 ] - Market Wire

Health Net Announces Appearance at Credit Suisse 2nd Annual Small & Mid Cap Conference

[ Wed, Sep 21st 2011 ] - Market Wire

Alnylam to Webcast Presentation at the JMP Securities Healthcare Conference

[ Wed, Sep 21st 2011 ] - Market Wire

ACADIA Pharmaceuticals to Present at the Sixth An .. ities Healthcare Conference on September 28, 2011

[ Wed, Sep 21st 2011 ] - Market Wire

ARIAD Announces Start of Enrollment in Phase 1/2 .. 3, an Investigational Dual Inhibitor of ALK and E

[ Wed, Sep 21st 2011 ] - Market Wire

Celgene Corporation to Present at JMP Securities Healthcare Conference 2011

[ Wed, Sep 21st 2011 ] - Market Wire

Independent Proxy Advisory Firms ISS and Glass Le .. hareholders Vote in Favour of Plan of Arrangement

[ Wed, Sep 21st 2011 ] - Market Wire

Smith & Nephew Introduces New Hysteroscopic Morce .. on Simulator Designed to Enhance Surgeon Training

Tue, September 20, 2011

[ Tue, Sep 20th 2011 ] - Market Wire

Jury Awards Medtronic $101 Million in Patent Suit against NuVasive

[ Tue, Sep 20th 2011 ] - Market Wire

Manny Villafaa Discusses FDA Update for Kips Bay Medical

[ Tue, Sep 20th 2011 ] - Market Wire

St. Jude Medical meldt Europese introductie van kleiner quadripolair pacingsysteem

[ Tue, Sep 20th 2011 ] - Market Wire

??????????????,?52???,2???????????????????ONGLYZAa" (????)???????(HbA1c)??

[ Tue, Sep 20th 2011 ] - Market Wire

St. Jude Medical annuncia il lancio in Europa di .. i stimolazione quadripolare di dimensioni ridotte

[ Tue, Sep 20th 2011 ] - Market Wire

Merck Joins Global Fight to Help Save Women's Lives During Pregnancy and Childbirth

[ Tue, Sep 20th 2011 ] - Market Wire

Pfizer Announces Expiration of Subsequent Offerin .. letion of Tender Offer for Shares of Icagen, Inc.

[ Tue, Sep 20th 2011 ] - Market Wire

Centric Health to Acquire Medical Imaging Centres Inc. and Rads 24/7 Teleradiology Consultants

[ Tue, Sep 20th 2011 ] - Market Wire

Covidien to Present at Jefferies 2011 Global Healthcare Conference

Mon, September 19, 2011

[ Mon, Sep 19th 2011 ] - Market Wire

Alere to Attend the Sixth Annual JMP Securities Healthcare Conference on September 27, 2011

[ Mon, Sep 19th 2011 ] - Market Wire

Alere Acquires Additional Shares of Axis-Shield

[ Mon, Sep 19th 2011 ] - Market Wire

NeuroMetrix Reports Product Milestone

[ Mon, Sep 19th 2011 ] - Market Wire

Wright Medical Group, Inc. Names Robert J. Palmisano President and Chief Executive Officer

[ Mon, Sep 19th 2011 ] - Market Wire

FDA Panel to Review AtriCurea?s Synergy Ablation System on October 26

[ Mon, Sep 19th 2011 ] - Market Wire

Inhibitex Commences Dosing of Phase 2 Clinical Tr .. of INX-189 in HCV Infected Genotype 2/3 Patients

[ Mon, Sep 19th 2011 ] - Market Wire

ONGLYZAa" (saxagliptin) (saxagliptina) adicionado .. abetes tipo 2 manteve redues nos nveis de acar no

[ Mon, Sep 19th 2011 ] - Market Wire

Extensin de un estudio en fase de investigacin de .. liptina) incorporado a la insulina en adultos con

[ Mon, Sep 19th 2011 ] - Market Wire

Cord Blood America Updates Investors on Laboratory Licensing

Sun, September 18, 2011

[ Sun, Sep 18th 2011 ] - Market Wire

Sangamo BioSciences Announces Presentation of Gro .. a From ZFN Therapeutic for HIV/AIDS at ICAAC 2011

Sat, September 17, 2011

[ Sat, Sep 17th 2011 ] - Market Wire

Dans le cadre de la prolongation d'une ©tude exp .. ptine) plus insuline chez les patients adultes at

[ Sat, Sep 17th 2011 ] - Market Wire

Dans le cadre de la prolongation d'une ©tude exp .. tine) plus insuline chez les patients adultes att

[ Sat, Sep 17th 2011 ] - Market Wire

Dans le cadre de la prolongation d';&# .. 4;;; ONGLYZAa" (saxagliptine) plus insu

[ Sat, Sep 17th 2011 ] - Market Wire

Dans le cadre de la prolongation d';&# .. e,;;;; ONGLYZAa" (saxagliptine) p

[ Sat, Sep 17th 2011 ] - Market Wire

Dans le cadre de la prolongation d';&# .. ntale,;;;;; ONGLYZAa" (saxagli

[ Sat, Sep 17th 2011 ] - Market Wire

ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic

[ Sat, Sep 17th 2011 ] - Market Wire

ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic

[ Sat, Sep 17th 2011 ] - Market Wire

ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic

[ Sat, Sep 17th 2011 ] - Market Wire

ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic

Fri, September 16, 2011

[ Fri, Sep 16th 2011 ] - Market Wire

Misonix Schedules Fourth Quarter and Year-End Fis .. nference Call;; September 20, 2011 at 4:30

[ Fri, Sep 16th 2011 ] - Market Wire

Fibrocell Science, Inc. Announces New Presentation Time at the UBS Global Life Sciences Conference

[ Fri, Sep 16th 2011 ] - Market Wire

NPS Pharmaceuticals Highlights Hypoparathyroidism .. al Meeting of American Society for Bone and Miner

[ Fri, Sep 16th 2011 ] - Market Wire

ONGLYZAa" (saxagliptin) toegevoegd aan insuline b .. ype 2 bood duurzame verlaging van het bloedsuiker

[ Fri, Sep 16th 2011 ] - Market Wire

ONGLYZAa" (saxagliptin) When Added to Insulin in .. aintained Reductions in Blood Sugar Levels (HbA1c

[ Fri, Sep 16th 2011 ] - Market Wire

BioLineRx to Present at Annual UBS Global Life Sciences Conference in New York on September 21st

[ Fri, Sep 16th 2011 ] - Market Wire

New data for once-daily linagliptin show durable efficacy over two years

[ Fri, Sep 16th 2011 ] - Market Wire

Centene Corporation Elects Orlando Ayala of Microsoft to Board of Directors

[ Fri, Sep 16th 2011 ] - Market Wire

Jazz Pharmaceuticals Announces Presentation at th .. e Sciences Conference in New York on September 20

Thu, September 15, 2011

[ Thu, Sep 15th 2011 ] - Market Wire

Covidien kondigt O&O-centrum in China aan

[ Thu, Sep 15th 2011 ] - Market Wire

InSite Vision Establishes Scientific Advisory Board

[ Thu, Sep 15th 2011 ] - Market Wire

Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer

[ Thu, Sep 15th 2011 ] - Market Wire

Covidien Announces R&D Center in China

[ Thu, Sep 15th 2011 ] - Market Wire

Covidien construye centro de investigacin y desarrollo en China

[ Thu, Sep 15th 2011 ] - Market Wire

BioLineRx Announces European Confirmation of Medi .. for BL-5010, for Non-surgical Removal of Skin Le

[ Thu, Sep 15th 2011 ] - Market Wire

Cubist Antibiotic Programs Featured in 49 Presentations at 51st ICAAC

[ Thu, Sep 15th 2011 ] - Market Wire

Cord Blood America CEO Statement to Shareholders

[ Thu, Sep 15th 2011 ] - Market Wire

ShangPharma Subsidiary and Jiangsu Hengrui Medici .. in Therapeutic Antibody Research and Development

Wed, September 14, 2011

[ Wed, Sep 14th 2011 ] - Market Wire

15-Year-Old High School Football Player in Louisiana Saved with ZOLL AED Plus

[ Wed, Sep 14th 2011 ] - Market Wire

Vanda Pharmaceuticals to Participate in UBS Global Life Sciences Conference

[ Wed, Sep 14th 2011 ] - Market Wire

Le New England Journal of Medicine publie des don .. MINATE da?INCIVEKMC (T©lapr©vir) sur la?h©pati

[ Wed, Sep 14th 2011 ] - Market Wire

Thirty-Five Health Management Hospitals Named Top .. s on Key Quality Measures by the Joint Commission

[ Wed, Sep 14th 2011 ] - Market Wire

Greatbatch, Inc. to Participate in the UBS Global Life Sciences Conference

[ Wed, Sep 14th 2011 ] - Market Wire

HealthSpring Among Fortunea?s 100 Fastest Growing Companies

[ Wed, Sep 14th 2011 ] - Market Wire

PPD Named to InformationWeek 500 List of U.S. Business Technology Innovators

[ Wed, Sep 14th 2011 ] - Market Wire

Astex Pharmaceuticals to Present at UBS Global Life Sciences Conference on September 21st

[ Wed, Sep 14th 2011 ] - Market Wire

Medtronic Pledges Action in Advance of United Nat .. ns High Level Meeting on Noncommunicable Diseases

Tue, September 13, 2011

[ Tue, Sep 13th 2011 ] - Market Wire

InterMune Announces Pricing of Concurrent Public .. of Common Stock and $135 Million Principal Amoun

[ Tue, Sep 13th 2011 ] - Market Wire

Cambridge Heart Expands Distribution into Latin America

[ Tue, Sep 13th 2011 ] - Market Wire

Human Genome Sciences Invites Investors to Listen .. ation at Bank of America Merrill Lynch Conference

[ Tue, Sep 13th 2011 ] - Market Wire

iCo Therapeutics CEO to Present &;; Act as .. nnual Drug Repositioning and Pipeline Enhancement

[ Tue, Sep 13th 2011 ] - Market Wire

LabCorp';s Zero Coupon Convertible Su .. ated Notes Due 2021 to Accrue Contingent Interest

[ Tue, Sep 13th 2011 ] - Market Wire

Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen,;; Inc.

[ Tue, Sep 13th 2011 ] - Market Wire

Compugen Announces Validation of Two Immune System Modulating Drug Candidates

[ Tue, Sep 13th 2011 ] - Market Wire

Seattle Genetics and Oxford BioTherapeutics to Collaborate on Antibody-Drug Conjugates for Cancer

[ Tue, Sep 13th 2011 ] - Market Wire

BioLineRx Announces Positive Preliminary Results .. I Clinical Trial of BL-1021 for Neuropathic Pain

Mon, September 12, 2011

[ Mon, Sep 12th 2011 ] - Market Wire

Alnylam Scientists and Collaborators Report Signi .. ery of RNAi Therapeutics at 2011 Oligonucleotides

[ Mon, Sep 12th 2011 ] - Market Wire

Dr. Mark Freedman to Join Opexaa?s Scientific Advisory Board

[ Mon, Sep 12th 2011 ] - Market Wire

New Research Indicates Treating Neonatal Respirat .. OSURF® Results in Lower Rate of Mortality Compar

[ Mon, Sep 12th 2011 ] - Market Wire

BioSante Pharmaceuticals Successfully Completes LibiGel® Pharmacokinetic Study

[ Mon, Sep 12th 2011 ] - Market Wire

InVivo Therapeutics Promotes Lauren Mitarotondo t .. ; Operations as InVivo Prepares for Human Studies

[ Mon, Sep 12th 2011 ] - Market Wire

Geron to Webcast Presentations at Upcoming Investor Conferences

[ Mon, Sep 12th 2011 ] - Market Wire

Curis Announces Submission of New Drug Applicatio .. h for Vismodegib in Advanced Basal Cell Carcinoma

[ Mon, Sep 12th 2011 ] - Market Wire

Tenet Refines 2011 Outlook in Advance of Investor Meetings

[ Mon, Sep 12th 2011 ] - Market Wire

SuperGen,;; Inc. Changes Name to Astex .. Inc.,;; Announces New Stock Ticker Symb

Sun, September 11, 2011

[ Sun, Sep 11th 2011 ] - Market Wire

Panmira und FLAP LLCs als Ausgrndungen von Amira Pharmaceuticals entstanden

Sat, September 10, 2011

[ Sat, Sep 10th 2011 ] - Market Wire

Questcor Provides Updated New Paid Prescription Trends

[ Sat, Sep 10th 2011 ] - Market Wire

Human Genome Sciences Invites Investors to Listen .. cast of Presentation at Morgan Stanley Conference

[ Sat, Sep 10th 2011 ] - Market Wire

Electromed,;; Inc. Fourth Quarter and Y .. Call Scheduled for September 13,;; 2011

[ Sat, Sep 10th 2011 ] - Market Wire

Exelixis Announces Webcasts of Upcoming Investor Conference Presentations

[ Sat, Sep 10th 2011 ] - Market Wire

Panmira y FLAP LLCs realizan una desinversin de Amira Pharmaceuticals

Fri, September 9, 2011

[ Fri, Sep 09th 2011 ] - Market Wire

Panmira und FLAP LLCs als Ausgrndungen von Amira Pharmaceuticals entstanden

[ Fri, Sep 09th 2011 ] - Market Wire

China Sky One Medical Announces Change of Board Directors

[ Fri, Sep 09th 2011 ] - Market Wire

Panmira og FLAP LLCs udsprang fra Amira Pharmaceuticals

[ Fri, Sep 09th 2011 ] - Market Wire

Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences

[ Fri, Sep 09th 2011 ] - Market Wire

Boston Scientific Issues Statement Regarding FDA .. Surgical Mesh to Treat Pelvic Organ Prolapse and

[ Fri, Sep 09th 2011 ] - Market Wire

Positive Results from Phase 2 Clinical Study of N .. Cancer Presented in Oral Session at the ASCO 2011

[ Fri, Sep 09th 2011 ] - Market Wire

Emergent BioSolutions Co-Hosts Biopreparedness Co .. with the French High Committee for Civil Defense

[ Fri, Sep 09th 2011 ] - Market Wire

Growing Clinical Evidence the Focus of Accuray&ap .. 9;s TomoTherapy Asia User Education Symposium

[ Fri, Sep 09th 2011 ] - Market Wire

Centric Health Announces Investor Event to Provide Strategic Corporate Update

Thu, September 8, 2011

[ Thu, Sep 08th 2011 ] - Market Wire

Covidien annonce les temps forts de sa r©union avec les investisseurs

[ Thu, Sep 08th 2011 ] - Market Wire

Health Net Announces Appearance at Morgan Stanley Global Healthcare Conference

[ Thu, Sep 08th 2011 ] - Market Wire

Isis Pharmaceuticals Hosts Dr. John Kastelein to .. term Data Recently Presented at ESC Congress 2011

[ Thu, Sep 08th 2011 ] - Market Wire

NeoStem Announces Participation in Multiple September Conferences

[ Thu, Sep 08th 2011 ] - Market Wire

Anthera Pharmaceuticals Announces Notice of Allow .. plication Covering A-002 Plus Statin Compositions

[ Thu, Sep 08th 2011 ] - Market Wire

Amgen to Present at the Morgan Stanley Global Healthcare Conference

[ Thu, Sep 08th 2011 ] - Market Wire

Abbott Named to the Dow Jones Sustainability Inde .. ear in Recognition of Leading Corporate Citizensh

[ Thu, Sep 08th 2011 ] - Market Wire

DiagnoCure announces third quarter 2011 earnings results

[ Thu, Sep 08th 2011 ] - Market Wire

Diagnocure To Present At Rodman &; Renshaw Annual .. lobal Investment Conference On September 13, 2011

Wed, September 7, 2011

[ Wed, Sep 07th 2011 ] - Market Wire

American Medical Alert Corp. Announces Date for I .. reholders and Deadline for Submitting Shareholder

[ Wed, Sep 07th 2011 ] - Market Wire

Unigene Appoints Industry Veteran Theron (Ted) Odlaug as New Independent Director to Board

[ Wed, Sep 07th 2011 ] - Market Wire

International Stem Cell to Present at the Rodman .. nual Global Investment Conference on September 12

[ Wed, Sep 07th 2011 ] - Market Wire

West to Present at Upcoming Investor Conferences

[ Wed, Sep 07th 2011 ] - Market Wire

CORRECTING and REPLACING A.M. Best Withdraws Rati .. UnitedHealthcare of Tennessee, Inc. Due to Merger

[ Wed, Sep 07th 2011 ] - Market Wire

Bankers Life and Casualty Company Partners with H .. to Offer Humana Medicare Prescription Drug Plans

[ Wed, Sep 07th 2011 ] - Market Wire

Nordion to Release Third Quarter 2011 Financial Results

[ Wed, Sep 07th 2011 ] - Market Wire

ThermoGenesis Presentation at Rodman & Renshaw Conference

Tue, September 6, 2011

[ Tue, Sep 06th 2011 ] - Market Wire

AMRI CFO to Present at the Rodman & Renshaw 13th Annual Healthcare Conference

[ Tue, Sep 06th 2011 ] - Market Wire

Acorda Therapeutics to Present at the Morgan Stanley Global Healthcare Conference

[ Tue, Sep 06th 2011 ] - Market Wire

ZIOPHARM Oncology Appoints Caesar J. Belbel as Ex .. Vice President, Chief Legal Officer and Secretary

[ Tue, Sep 06th 2011 ] - Market Wire

Almost Family to Present at the Baird 2011 Health Care Conference

[ Tue, Sep 06th 2011 ] - Market Wire

Unilife to Participate in Two Investor Conferences

[ Tue, Sep 06th 2011 ] - Market Wire

Anadys Pharmaceuticals Updates Its Presentation Date at the Stifel Nicolaus Healthcare Conference

[ Tue, Sep 06th 2011 ] - Market Wire

Universal American Announces Extension of Exchange Offer

[ Tue, Sep 06th 2011 ] - Market Wire

Louisa Spencer Announces Acquisition of Shares of Hamilton Thorne Ltd.

Mon, September 5, 2011

[ Mon, Sep 05th 2011 ] - Market Wire

QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers

[ Mon, Sep 05th 2011 ] - Market Wire

Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board

[ Mon, Sep 05th 2011 ] - Market Wire

DaVita Closes Acquisition of DSI Renal, Inc.

Sun, September 4, 2011

[ Sun, Sep 04th 2011 ] - Market Wire

Gilead Amends Study Design for Ongoing Hepatitis .. e GS 9190, Pegylated Interferon and Ribavirin, an

[ Sun, Sep 04th 2011 ] - Market Wire

MSA whlt Dr. Thomas Muschter zum Vice President des Unternehmens

Sat, September 3, 2011

[ Sat, Sep 03rd 2011 ] - Market Wire

Alere Inc. Declares Cash Dividend on Its Series B Convertible Perpetual Preferred Stock

[ Sat, Sep 03rd 2011 ] - Market Wire

Catasys Announces Reverse Stock Split

[ Sat, Sep 03rd 2011 ] - Market Wire

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Baird Conference

[ Sat, Sep 03rd 2011 ] - Market Wire

Magellan Health Services Recommended for Contract .. dminister Louisiana Behavioral Health Partnership

[ Sat, Sep 03rd 2011 ] - Market Wire

Orthofix International to Participate in the 2011 Morgan Stanley Global Healthcare Conference

[ Sat, Sep 03rd 2011 ] - Market Wire

Positron to Exhibit at the American Society of Nuclear Cardiology 16th Annual Scientific Session

Fri, September 2, 2011

[ Fri, Sep 02nd 2011 ] - Market Wire

Dr. Reddya?s Announces Start of Phase II Study wi .. ETP Inhibitor, DRL-17822 in Dyslipidemia Patients

[ Fri, Sep 02nd 2011 ] - Market Wire

Amgen to Present at the Stifel Nicolaus Healthcare Conference

[ Fri, Sep 02nd 2011 ] - Market Wire

The Ensign Group to Present at the Stifel Nicolaus 2011 Healthcare Conference on September 8th

[ Fri, Sep 02nd 2011 ] - Market Wire

SuperGen, Inc. to Change Name and Stock Ticker Symbol

[ Fri, Sep 02nd 2011 ] - Market Wire

Vertex Announces Webcast of its Presentations at Two Investor Conferences

[ Fri, Sep 02nd 2011 ] - Market Wire

MSA Elects Dr. Thomas Muschter to Vice President

[ Fri, Sep 02nd 2011 ] - Market Wire

Senetek Announces Exercise of Put Option With Respect to Relief Canyon Project

[ Fri, Sep 02nd 2011 ] - Market Wire

Hawaii, Arkansas and Oklahoma Lead the Nation for .. Workforce, Reveals Quest Diagnostics Drug Testing

Thu, September 1, 2011

[ Thu, Sep 01st 2011 ] - Market Wire

Brookdale Senior Living Completes Acquisition of .. and Right of First Offer on Chartwell Communities

[ Thu, Sep 01st 2011 ] - Market Wire

Advitech Retains Investor Relations Firm

[ Thu, Sep 01st 2011 ] - Market Wire

Nuvo Research to Present at Upcoming Healthcare Conferences

[ Thu, Sep 01st 2011 ] - Market Wire

Burcon files NASDAQ listing application

[ Thu, Sep 01st 2011 ] - Market Wire

STRYKER firma un acuerdo definitivo para adquirir CONCENTRIC MEDICAL, Inc.

[ Thu, Sep 01st 2011 ] - Market Wire

Help Your Favorite Charity Win $1,000 from Cold-EEZE®!

[ Thu, Sep 01st 2011 ] - Market Wire

Delcath Announces Top-Line Results From Metastati .. ohort in Phase II Trial of Chemosaturation System

Wed, August 31, 2011

[ Wed, Aug 31st 2011 ] - Market Wire

Community Health Systems to Participate in Robert W. Baird & Co.a?s 2011 Health Care Conference

[ Wed, Aug 31st 2011 ] - Market Wire

Alexion to Present at the Stifel Nicolaus Healthcare Conference 2011

[ Wed, Aug 31st 2011 ] - Market Wire

Cipher receives Health Canada approval for extended-release tramadol

[ Wed, Aug 31st 2011 ] - Market Wire

Five Star Quality Care, Inc. to Present at the St .. colaus Healthcare Conference on September 7, 2011

[ Wed, Aug 31st 2011 ] - Market Wire

Salix Pharmaceuticals to Present at Three Investment Conferences in September

[ Wed, Aug 31st 2011 ] - Market Wire

Repligen to Present at Upcoming Investor Conferences

[ Wed, Aug 31st 2011 ] - Market Wire

GTx Announces Panel Discussion at Citia?s 6th Annual Biotech Day

[ Wed, Aug 31st 2011 ] - Market Wire

AVEO Pharmaceuticals, Inc. to Present at Upcoming Investment Conferences

Tue, August 30, 2011

[ Tue, Aug 30th 2011 ] - Market Wire

HealthSouth to Present at Morgan Stanley Global Healthcare Conference

[ Tue, Aug 30th 2011 ] - Market Wire

Unilife Corporation Announces Preliminary Financi .. sults for the Fourth Quarter and Fiscal Year 2011

[ Tue, Aug 30th 2011 ] - Market Wire

Luminex Corporation to Present at Upcoming Investment Conferences In September

[ Tue, Aug 30th 2011 ] - Market Wire

Adamis Pharmaceuticals Begins Prostate Cancer Trial

[ Tue, Aug 30th 2011 ] - Market Wire

[ Tue, Aug 30th 2011 ] - Market Wire

Unigene Successfully Defends its Robust Intellectual Property Portfolio

[ Tue, Aug 30th 2011 ] - Market Wire

Invacare Social Media Campaign Recognizes aReal Lifea? Winners

[ Tue, Aug 30th 2011 ] - Market Wire

Progenics and Salix Announce FDA Acceptance of sN .. g for RELISTOR® in Patients with Non-Cancer Pain

Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York

_{//health-fitness.news-articles.net/content/2011/ .. global-life-sciences-conference-in-new-york.html}
^{Published in Health and Fitness on Wednesday, September 14th 2011 at 18:40 GMT by Market Wire}

Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the... -- SAN FRANCISCO, Sept. 14, 2011 /PRNewswire/ --

Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City

[ ]

SAN FRANCISCO, Sept. 14, 2011 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: [ NKTR ]) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the upcoming UBS 2011 Global Life Sciences Conference in New York at the Grand Hyatt Hotel on Tuesday, September 20, 2011 at 10:00 a.m. Eastern time.

The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: [ http://www.nektar.com ]. This Webcast will be available for replay until October 25, 2011.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for NKTR-118, an investigational drug candidate, being evaluated in Phase 3 clinical studies as a once-daily, oral tablet for the treatment of opioid-induced constipation. The agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of NKTR-118 and an opioid. NKTR-181, a novel mu-opioid analgesic molecule, is being evaluated in Phase 1 clinical studies. In oncology, NKTR-102, a novel topoisomerase I-inhibitor, is being evaluated in Phase 2 clinical studies for the treatment of breast, ovarian and colorectal cancers.

Nektar's technology has enabled seven approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia.

Nektar is headquartered in San Francisco, California, with additional R&D operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at [ http://www.nektar.com ].

Jennifer Ruddock of Nektar Therapeutics, +1-415-482-5585, [ jruddock@nektar.com ]

SOURCE Nektar Therapeutics

[ Back to top ]

RELATED LINKS
[ http://www.nektar.com ]

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire